HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Boosted by Invesco Ltd.

Invesco Ltd. lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 50.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,446,198 shares of the company's stock after buying an additional 821,425 shares during the period. Invesco Ltd. owned about 2.83% of HealthEquity worth $216,171,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of HQY. T. Rowe Price Investment Management Inc. purchased a new position in shares of HealthEquity during the 4th quarter worth approximately $78,107,000. Westfield Capital Management Co. LP acquired a new stake in shares of HealthEquity in the 1st quarter worth approximately $49,787,000. Premier Fund Managers Ltd grew its holdings in shares of HealthEquity by 3,601.6% in the 1st quarter. Premier Fund Managers Ltd now owns 409,992 shares of the company's stock worth $35,610,000 after acquiring an additional 398,916 shares during the period. Iron Triangle Partners LP acquired a new stake in shares of HealthEquity in the 4th quarter worth approximately $32,202,000. Finally, WCM Investment Management LLC acquired a new stake in shares of HealthEquity in the 1st quarter worth approximately $20,230,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on HQY shares. Deutsche Bank Aktiengesellschaft upped their price target on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. Raymond James Financial restated a "strong-buy" rating and issued a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Bank of America upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. JMP Securities upped their price target on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Finally, The Goldman Sachs Group raised their price target on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, HealthEquity has an average rating of "Buy" and an average price target of $118.55.

Insider Activity at HealthEquity

In other news, Director Jon Kessler sold 134,183 shares of HealthEquity stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the sale, the director directly owned 253,510 shares of the company's stock, valued at approximately $28,413,400.80. The trade was a 34.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the transaction, the executive vice president owned 75,689 shares in the company, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is owned by insiders.

HealthEquity Trading Up 2.8%

Shares of HQY stock traded up $2.46 during mid-day trading on Friday, hitting $89.89. 894,425 shares of the company's stock were exchanged, compared to its average volume of 838,496. HealthEquity, Inc. has a fifty-two week low of $72.79 and a fifty-two week high of $116.65. The stock has a 50-day simple moving average of $98.42 and a two-hundred day simple moving average of $97.27. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a market cap of $7.77 billion, a price-to-earnings ratio of 65.61, a PEG ratio of 1.39 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The business had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. During the same quarter last year, the firm earned $0.80 earnings per share. Equities analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.